 |
Nintedanib |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| EU Market Approval | EU |
| EU Designation Date | 2016-08-29 00:00:00 |
| Sponsor | Boehringer Ingelheim International GmbH |
| |
Nintedanib |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| EU Market Approval | EU |
| EU Designation Date | 2016-08-29 00:00:00 |
| Sponsor | Boehringer Ingelheim International GmbH |